Kam S. Ho‐Mok

915 total citations
12 papers, 649 citations indexed

About

Kam S. Ho‐Mok is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Kam S. Ho‐Mok has authored 12 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Kam S. Ho‐Mok's work include Drug Transport and Resistance Mechanisms (9 papers), Lipid Membrane Structure and Behavior (4 papers) and Pediatric Hepatobiliary Diseases and Treatments (4 papers). Kam S. Ho‐Mok is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Lipid Membrane Structure and Behavior (4 papers) and Pediatric Hepatobiliary Diseases and Treatments (4 papers). Kam S. Ho‐Mok collaborates with scholars based in Netherlands, Austria and United Kingdom. Kam S. Ho‐Mok's co-authors include Coen C. Paulusma, Ronald P.J. Oude Elferink, Rudi de Waart, Arthur J. Verhoeven, P. M. Hilarius, Alexander S. Knisely, Laura N. Bull, Frank G. Schaap, Hans R. Waterham and Ronald J. A. Wanders and has published in prestigious journals such as Hepatology, International Journal of Molecular Sciences and Cellular and Molecular Life Sciences.

In The Last Decade

Kam S. Ho‐Mok

11 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kam S. Ho‐Mok Netherlands 8 368 315 220 220 99 12 649
Rudi de Waart Netherlands 5 332 0.9× 246 0.8× 201 0.9× 122 0.6× 55 0.6× 6 560
Sotaro Naoi Japan 8 189 0.5× 127 0.4× 78 0.4× 66 0.3× 31 0.3× 8 275
José M. Ramos Pittol Netherlands 11 181 0.5× 122 0.4× 173 0.8× 127 0.6× 75 0.8× 19 415
Julien Gautherot France 9 280 0.8× 194 0.6× 116 0.5× 115 0.5× 74 0.7× 10 418
H. Kurosawa Japan 8 98 0.3× 136 0.4× 158 0.7× 145 0.7× 141 1.4× 16 395
Luxing Pan United States 9 213 0.6× 169 0.5× 150 0.7× 77 0.3× 19 0.2× 13 394
Kathleen Deutschmann Germany 4 169 0.5× 146 0.5× 124 0.6× 106 0.5× 106 1.1× 9 363
Milica Stefanović Spain 9 78 0.2× 104 0.3× 146 0.7× 121 0.6× 96 1.0× 26 454
Kazuhiro Kagotani Japan 10 407 1.1× 122 0.4× 278 1.3× 46 0.2× 10 0.1× 16 646
Guangyan Wei China 10 86 0.2× 72 0.2× 158 0.7× 138 0.6× 117 1.2× 30 419

Countries citing papers authored by Kam S. Ho‐Mok

Since Specialization
Citations

This map shows the geographic impact of Kam S. Ho‐Mok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kam S. Ho‐Mok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kam S. Ho‐Mok more than expected).

Fields of papers citing papers by Kam S. Ho‐Mok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kam S. Ho‐Mok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kam S. Ho‐Mok. The network helps show where Kam S. Ho‐Mok may publish in the future.

Co-authorship network of co-authors of Kam S. Ho‐Mok

This figure shows the co-authorship network connecting the top 25 collaborators of Kam S. Ho‐Mok. A scholar is included among the top collaborators of Kam S. Ho‐Mok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kam S. Ho‐Mok. Kam S. Ho‐Mok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Chang, Jung‐Chin, Shu‐Hao Hsu, Suzanne Duijst, et al.. (2025). ATP8B1 Deficiency Causes Phosphodiesterase 4‐Mediated Glucagon Resistance and Impaired Gluconeogenesis in Mouse and Human Liver. Liver International. 45(9). e70306–e70306.
2.
Koelink, Pim J., Suzanne Duijst, Manon van Roest, et al.. (2024). The Phospholipid Flippase ATP8B1 is Involved in the Pathogenesis of Ulcerative Colitis via Establishment of Intestinal Barrier Function. Journal of Crohn s and Colitis. 18(7). 1134–1146. 6 indexed citations
3.
Ho‐Mok, Kam S., Nicole N. van der Wel, Anita E. Grootemaat, et al.. (2022). The phospholipid flippase ATP8B1 is required for lysosomal fusion in macrophages. Cell Biochemistry and Function. 40(8). 914–925. 3 indexed citations
4.
Chang, Jung‐Chin, et al.. (2022). ATP8B1 Deficiency Results in Elevated Mitochondrial Phosphatidylethanolamine Levels and Increased Mitochondrial Oxidative Phosphorylation in Human Hepatoma Cells. International Journal of Molecular Sciences. 23(20). 12344–12344. 2 indexed citations
5.
Jonge, Hugo R. de, Jung‐Chin Chang, Kam S. Ho‐Mok, et al.. (2016). The phospholipid flippase ATP8B1 mediates apical localization of the cystic fibrosis transmembrane regulator. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1863(9). 2280–2288. 9 indexed citations
6.
Ghiboub, Mohammed, Jing Zhao, Remco van Dijk, et al.. (2016). Phospholipid flippases attenuate LPS-induced TLR4 signaling by mediating endocytic retrieval of Toll-like receptor 4. Cellular and Molecular Life Sciences. 74(4). 715–730. 31 indexed citations
7.
Waart, Dirk R. de, Suzanne Duijst, Kam S. Ho‐Mok, et al.. (2016). ATP11C targets basolateral bile salt transporter proteins in mouse central hepatocytes. Hepatology. 64(1). 161–174. 22 indexed citations
8.
Waart, Dirk R. de, Kam S. Ho‐Mok, Merit M. Tabbers, et al.. (2014). The lipid flippase heterodimer ATP8B1–CDC50A is essential for surface expression of the apical sodium-dependent bile acid transporter (SLC10A2/ASBT) in intestinal Caco-2 cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(12). 2378–2386. 33 indexed citations
9.
Vaz, Frédéric M., Coen C. Paulusma, Hidde H. Huidekoper, et al.. (2014). Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: Conjugated hypercholanemia without a clear clinical phenotype. Hepatology. 61(1). 260–267. 148 indexed citations
10.
11.
Paulusma, Coen C., Kam S. Ho‐Mok, Rudi de Waart, et al.. (2007). ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity. Hepatology. 47(1). 268–278. 183 indexed citations
12.
Paulusma, Coen C., Cindy Kunne, Kam S. Ho‐Mok, et al.. (2006). Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Hepatology. 44(1). 195–204. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rudi de Waart Breakdown of academic impact, for papers by Sotaro Naoi Breakdown of academic impact, for papers by José M. Ramos Pittol Breakdown of academic impact, for papers by Julien Gautherot Breakdown of academic impact, for papers by H. Kurosawa Breakdown of academic impact, for papers by Luxing Pan Breakdown of academic impact, for papers by Kathleen Deutschmann Breakdown of academic impact, for papers by Milica Stefanović Breakdown of academic impact, for papers by Kazuhiro Kagotani Breakdown of academic impact, for papers by Guangyan Wei
Rankless by CCL
2026